the aid library

LIST OPTIONS

Filter

2877

Sort by:

Direction:

Download (817)

View PDF (992)

Zero by 30: the global strategic plan to end human deaths from dog-mediated rabies by 2030

World Health Organization (WHO) (2018) C_WHO

An estimated 59 000 people die from rabies each year. That’s one person every nine minutes of every day, 40% of whom are children living in Asia and Africa. As dog bites cause almost all human cases, we can prevent rabies deaths by increasing awareness, vaccinating dogs to prevent the disease at i... more

Download (239)

View PDF (428)

An Expanded DOTS Framework for Effective Tuberculosis Control

World Health Organization (2002) C_WHO

Stop TB Communicable Diseases

Download (157)

View PDF (301)

Global burden of mental disorders among children aged 5–14 years

M. L. Baranne; B. Falissard Child and Adolescent Psychiatry and Mental Health (2018) CC

The global burden of disease (GBD) study provides information about fatal and non-fatal health outcomes around the world. The objective of this work is to describe the burden of mental disorders among children aged 5–14 years in each of the six regions of the World Health Organisation. Data come ... more

Download (458)

View PDF (714)

Training catalogue for outbreak response

World Health Organization WHO (2016) C_WHO

The training courses cover a wide range of technical and disease topics, to help prepare response workers with the skills and knowledge they need in a health emergency.

Download (2500)

View PDF (1551)

Reproductive, Maternal, Newborn, and Child Health

Robert E. Black, Ramanan Laxminarayan, Marleen Temmerman; et al. International Bank for Reconstruction and Development The World Bank (2016) CC

Disease Control Priorities –3rdEdition, Volume 2. This book focuses on maternal conditions, childhood illness, and malnutrition. Specifically, the chapters address acute illness and undernutrition in children, principally under age 5. It also covers maternal mortality, morbidity, stillbirth, and ... more

Download (80)

View PDF (138)

JPS 2012-2016

UNAIDS (2019) C2

Zero new HIV infections Zero Discrimination Zero AIDS related deaths Accessed: 04.10.2019

Download (323)

View PDF (542)

Weak surveillance and policy attention to cancer in global health: the example of Mozambique

Lorenzoni, C; Oliveras, Laura; Vilajeliu, A, et al. (2018) CC

Cancer is an emerging public health problem in sub-Saharan Africa due to population growth, ageing and westernisation of lifestyles. In this piece, we use data from Mozambique over a 50-year period to illustrate cancer epidemiological trends in low-income and middle-income countries to hypothesise ... more

Download (112)

View PDF (144)

Handbook for the Management of Public Health Events in Air Transport

World Health Organization WHO (2016) C_WHO

Updated with information on Ebola virus disease and Middle East respiratory syndrome coronavirus A wide variety of health events ranging in severity may occur related to air transport, requiring different responses or, perhaps, no response at all. The target audience for this guidance document incl... more

Download (106)

View PDF (134)

Laboratory readiness and response for novel coronavirus (2019-nCoV) in expert laboratories in 30 EU/EEA countries

Reusken C. B. E. M., E. K. Broberg, B. Haagmans et al. Eurosurveillance (2020) C2

Timely detection of novel coronavirus (2019-nCoV) infection cases is crucial to interrupt the spread of this virus. We assessed the required expertise and capacity for molecular detection of 2019-nCoV in specialised laboratories in 30 European Union/European Economic Area (EU/EEA) countries. Thirty-... more

Download (72)

View PDF (1042)

The Role of Nursing Homes in the Spread of Antimicrobial Resistance Over the Healthcare Network

van den Dool C., PhD; A. Haenen; T. Leenstra, MD, PhD; et al. (2016) C2

The spread of antimicrobial-resistant microorganisms poses anincreasing threat to affordable modern health care. In the Netherlands, efforts to control the dispersal of known and novel antimicrobial-resistant organisms have been mostly implemented at the hospital level. However, recent studies have ... more

Download (86)

View PDF (107)

Inactivation of Severe Acute Respiratory Syndrome Coronavirus 2 by WHO-Recommended Hand Rub Formulations and Alcohols

Kratzel, A.; D. Todt, P. V’kovski, et al. (2020) CC

Emerg Infect Dis. 2020 Jul [date cited]. https://doi.org/10.3201/eid2607.200915 Infection control instructions call for use of alcohol-based hand rub solutions to inactivate severe acute respiratory syndrome coronavirus 2. We determined the virucidal activity of World Health Organization–recommen... more

Download (65)

View PDF (695)

Physical distancing, face masks, and eye protection to prevent person-to-person transmission of SARS-CoV-2 and COVID-19: a systematic review and meta-analysis
recommended

Chu, D.K.; E.A Akl, S. Duda, et al. (2020) CC

a systematic review and meta-analysis Derek K Chu et al. on behalf of the COVID-19 Systematic Urgent Review Group Effort (SURGE) study authors. Published: The Lancet June 01, 2020 DOI: https://doi.org/10.1016S0140-6736(20)31142-9 'We did a systematic review of 172 observational studies in health-... more

Download (200)

View PDF (231)

Vaincre la méningite à l'horizon 2030 une feulle de route mondiale

Organisation Mondiale de la Santé OMS (2021) CC

La méningite est mortelle et débilitante ; elle frappe brutalement ; elle a de graves conséquences sanitaires, économiques et sociales et touche tous les âges de la vie dans tous les pays du monde. La méningite bactérienne peut être à l’origine d’épidémies, entraîner la mort dans les... more

Download (112)

View PDF (186)

Heat waves and human health

Lee, V.; F. Zermoglio; K.L.Ebi; et al. USAID (2019) C1

Emerging evidence and experience to inform risk management in a warming world

Download (99)

View PDF (168)

Monkeypox: Current status in West and Central Africa

World Health Organization (WHO) (2018) C_WHO

Monkeypox is an emerging viral zoonosis with symptoms similar to those observed in smallpox patients, although less severe. Since the global eradication of smallpox in 1980, monkeypox has emerged as the most important orthopoxvirus in humans. The Advisory Committee on Variola Virus Research (ACVVR) ... more

Download (82)

View PDF (187)

TDR Annual Report 2018: Building the science of solutions

World Health Organization WHO (2019) C2

TDR (Tropical Disease Research) Annual Report 2018

Download (129)

View PDF (164)

Keeping the vector out: housing improvements for vector control and sustainable development

Kraef, C.; Röbbel, N. World Health Organization WHO (2017) C_WHO

Vector-borne diseases are responsible for 17% of the global burden of communicable diseases and more than 500 000 deaths annually. The ambitious global targets for the control of vector-borne diseases come in the context of the (re-)emergence of diseases, increasing resistances to insecticides and u... more

Download (245)

View PDF (328)

Therapeutics and COVID-19 (Living Guideline, 10 November 2023)

World Health Organization WHO (2023) C_WHO

WHO has updated its guidelines for COVID-19 therapeutics, with revised recommendations for patients with non-severe COVID-19. This is the 13th update to these guidelines. Updated risk rates for hospital admission in patients with non-severe COVID-19 The guidance includes updated risk rates for... hospital admission in patients with non-severe COVID-19. The current COVID-19 virus variants tend to cause less severe disease while immunity levels are higher due to vaccination, leading to lower risks of severe illness and death for most patients. This update includes new baseline risk estimates for hospital admission in patients with non-severe COVID-19. The new ‘moderate risk’ category now includes people previously considered to be high risk including older people and/or those with chronic conditions, disabilities, and comorbidities of chronic disease. The updated risk estimates will assist healthcare professionals to identify individuals at high, moderate or low risk of hospital admission, and to tailor treatment according to WHO guidelines: **High: **People who are immunosuppressed remain at higher risk if they contract COVID-19, with an estimated hospitalization rate of 6%. **Moderate: **People over 65 years old, those with conditions like obesity, diabetes and/or chronic conditions including chronic obstructive pulmonary disease, kidney or liver disease, cancer, people with disabilities and those with comorbidities of chronic disease are at moderate risk, with an estimated hospitalization rate of 3%. Low: Those who are not in the high or moderate risk categories are at low risk of hospitalization (0.5%). Most people are low risk. Review of COVID-19 treatments for people with non-severe COVID-19 WHO continues to strongly recommend nirmatrelvir-ritonavir (also known by its brand name ‘Paxlovid’) for people at high-risk and moderate risk of hospitalization. The recommendations state that nirmatrelvir-ritonavir is considered the best choice for most eligible patients, given its therapeutic benefits, ease of administration and fewer concerns about potential harms. Nirmatrelvir-ritonavir was first recommended by WHO in April 2022. If nirmatrelvir-ritonavir is not available to patients at high-risk of hospitalization, WHO suggests the use of molnupiravir or remdesivir instead. WHO suggests against the use of molnupiravir and remdesivir for patients at moderate risk, judging the potential harms to outweigh the limited benefits in patients at moderate risk of hospital admission. For people at low risk of hospitalization, WHO does not recommend any antiviral therapy. Symptoms like fever and pain can continue to be managed with analgesics like paracetamol. WHO also recommends against use of a new antiviral (VV116) for patients, except in clinical trials. The update also includes a strong recommendation against the use of ivermectin for patients with non-severe COVID-19. WHO continues to advise that in patients with severe or critical COVID-19, ivermectin should only be used in clinical trials. more

Download (183)

View PDF (143)

Clinical management of diphtheria: guideline

World Health Organization WHO (2024) C_WHO

WHO has published the first-ever guidance on the clinical management of diphtheria. The only previously available guidance was an operational protocol. The new guidance followed the rigorous process for developing guidance at WHO. It addresses the use of Diphtheria Antitoxin (DAT) in the treatmen... more

Download (4)

View PDF (8)

Guidelines for the prevention, management and care of diabetes mellitus

World Health Organization WHO (2006) C_WHO

Diabetes mellitus is one of the most common noncommunicable diseases worldwide. In the Eastern Mediterranean Region there has been a rapid increase in the incidence of diabetes mellitus and it is now the fourth leading cause of death. The increasing prevalence of diabetes mellitus, the emergence of ... more

Physical distancing, face masks, and eye protection to prevent person-to-person transmission of SARS-CoV-2 and COVID-19: a systematic review and meta-analysis recommended

Physical distancing, face masks, and eye protection to prevent person-to-person transmission of SARS-CoV-2 and COVID-19: a systematic review and meta-analysis
recommended